A detailed history of Two Sigma Investments, LP transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Two Sigma Investments, LP holds 919,077 shares of IONS stock, worth $29.9 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
919,077
Previous 1,028,142 10.61%
Holding current value
$29.9 Million
Previous $49 Million 24.86%
% of portfolio
0.09%
Previous 0.12%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$40.06 - $51.86 $4.37 Million - $5.66 Million
-109,065 Reduced 10.61%
919,077 $36.8 Million
Q2 2024

Aug 14, 2024

SELL
$36.45 - $47.7 $2.03 Million - $2.66 Million
-55,737 Reduced 5.14%
1,028,142 $49 Million
Q1 2024

May 15, 2024

BUY
$42.03 - $53.55 $11.9 Million - $15.1 Million
282,431 Added 35.24%
1,083,879 $47 Million
Q4 2023

Feb 14, 2024

BUY
$43.39 - $51.63 $14.1 Million - $16.8 Million
325,391 Added 68.35%
801,448 $40.5 Million
Q3 2023

Nov 14, 2023

BUY
$38.5 - $47.13 $10.1 Million - $12.4 Million
262,685 Added 123.11%
476,057 $21.6 Million
Q2 2023

Aug 14, 2023

BUY
$34.73 - $43.33 $6.61 Million - $8.25 Million
190,292 Added 824.49%
213,372 $8.75 Million
Q1 2023

May 15, 2023

SELL
$33.58 - $41.2 $5.98 Million - $7.34 Million
-178,187 Reduced 88.53%
23,080 $824,000
Q4 2022

Feb 14, 2023

SELL
$37.12 - $46.52 $3.4 Million - $4.27 Million
-91,727 Reduced 31.31%
201,267 $7.6 Million
Q3 2022

Nov 14, 2022

SELL
$36.54 - $48.66 $9.76 Million - $13 Million
-267,037 Reduced 47.68%
292,994 $13 Million
Q2 2022

Aug 15, 2022

SELL
$31.71 - $43.0 $6.98 Million - $9.47 Million
-220,225 Reduced 28.22%
560,031 $20.7 Million
Q1 2022

May 16, 2022

BUY
$29.88 - $37.04 $5.54 Million - $6.87 Million
185,371 Added 31.16%
780,256 $28.9 Million
Q4 2021

Feb 14, 2022

BUY
$25.61 - $35.1 $7.19 Million - $9.85 Million
280,751 Added 89.37%
594,885 $18.1 Million
Q3 2021

Nov 15, 2021

BUY
$33.54 - $40.55 $256,446 - $310,045
7,646 Added 2.49%
314,134 $10.5 Million
Q2 2021

Aug 16, 2021

BUY
$34.54 - $47.25 $4.17 Million - $5.71 Million
120,768 Added 65.03%
306,488 $12.2 Million
Q1 2021

May 17, 2021

BUY
$42.51 - $63.78 $787,072 - $1.18 Million
18,515 Added 11.07%
185,720 $8.35 Million
Q4 2020

Feb 16, 2021

SELL
$45.3 - $60.27 $35.6 Million - $47.3 Million
-784,931 Reduced 82.44%
167,205 $9.45 Million
Q3 2020

Nov 16, 2020

BUY
$47.45 - $62.95 $16.2 Million - $21.5 Million
341,825 Added 56.01%
952,136 $45.2 Million
Q2 2020

Aug 14, 2020

BUY
$46.85 - $61.05 $2.92 Million - $3.8 Million
62,314 Added 11.37%
610,311 $36 Million
Q1 2020

May 15, 2020

SELL
$41.6 - $63.4 $3.9 Million - $5.95 Million
-93,788 Reduced 14.61%
547,997 $25.9 Million
Q4 2019

Feb 14, 2020

SELL
$53.85 - $65.27 $1.03 Million - $1.25 Million
-19,220 Reduced 2.91%
641,785 $38.8 Million
Q3 2019

Nov 14, 2019

SELL
$59.06 - $72.15 $38.6 Million - $47.2 Million
-654,074 Reduced 49.74%
661,005 $39.6 Million
Q2 2019

Aug 14, 2019

BUY
$62.09 - $86.14 $32.8 Million - $45.5 Million
528,669 Added 67.23%
1,315,079 $84.5 Million
Q1 2019

May 15, 2019

BUY
$52.92 - $81.17 $3.12 Million - $4.78 Million
58,865 Added 8.09%
786,410 $63.8 Million
Q4 2018

Feb 14, 2019

BUY
$43.37 - $59.54 $8.15 Million - $11.2 Million
187,876 Added 34.81%
727,545 $39.3 Million
Q3 2018

Nov 14, 2018

BUY
$42.88 - $53.7 $16.7 Million - $20.9 Million
389,731 Added 259.93%
539,669 $27.8 Million
Q2 2018

Aug 14, 2018

SELL
$40.53 - $50.7 $14.4 Million - $18.1 Million
-356,031 Reduced 70.37%
149,938 $6.25 Million
Q1 2018

May 15, 2018

BUY
$44.08 - $55.05 $14.8 Million - $18.5 Million
335,809 Added 197.35%
505,969 $22.3 Million
Q4 2017

Feb 14, 2018

BUY
$50.3 - $64.39 $8.3 Million - $10.6 Million
164,947 Added 3164.15%
170,160 $8.56 Million
Q3 2017

Nov 14, 2017

BUY
$45.56 - $59.57 $237,504 - $310,538
5,213
5,213 $264,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $4.61B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.